For home health agencies, the CY 2027 Home Health Proposed Rule (CMS-1844-P) is, first and foremost, a quality-program story. Yes, it sets next year's payment rates, and we'll cover that up front because you'll want the headline number. But the developments most likely to shape how you plan sit in the quality reporting sections: what CMS is confirming for the Home Health Quality Reporting Program (HH QRP) and the Expanded Home Health Value-Based Purchasing (HHVBP) model, and how the agency is signaling it may eventually connect the two.

After seeing promising preliminary results, our customer Amedisys is expanding a pilot program that aims to lower overall costs through fewer readmissions. The outcomes from the pilot and future results from the program will be evaluated against Strategic Healthcare Programs' (SHP) benchmark data on 3 metrics: hospital readmission rates, functional status of the patient and shortness of breath.

As one of our most popular reports, the Clinical Executive Advantage serves as a starting point for high level data analysis across a wide spectrum of clinically oriented home health quality metrics.

Although many agencies initially fought OASIS, most would be reluctant to give it up today and lose the valuable clinical insights gained through its use.

Too many patients are admitted in the final 72 hours of life, creating havoc and distress for patients, family members and hospice providers.